Illinois Municipal Retirement Fund Sells 27,103 Shares of Henry Schein, Inc. $HSIC

Illinois Municipal Retirement Fund reduced its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 26.7% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 74,335 shares of the company’s stock after selling 27,103 shares during the period. Illinois Municipal Retirement Fund owned about 0.06% of Henry Schein worth $5,430,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Vanguard Personalized Indexing Management LLC increased its stake in shares of Henry Schein by 3.5% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 4,669 shares of the company’s stock worth $341,000 after purchasing an additional 157 shares in the last quarter. Equitable Trust Co. grew its holdings in Henry Schein by 3.1% during the second quarter. Equitable Trust Co. now owns 5,317 shares of the company’s stock valued at $388,000 after purchasing an additional 158 shares during the period. TD Asset Management Inc grew its holdings in Henry Schein by 0.8% during the second quarter. TD Asset Management Inc now owns 22,016 shares of the company’s stock valued at $1,608,000 after purchasing an additional 164 shares during the period. Radnor Capital Management LLC increased its position in Henry Schein by 1.6% in the second quarter. Radnor Capital Management LLC now owns 11,415 shares of the company’s stock worth $834,000 after buying an additional 180 shares in the last quarter. Finally, Simon Quick Advisors LLC raised its stake in shares of Henry Schein by 5.5% in the second quarter. Simon Quick Advisors LLC now owns 3,466 shares of the company’s stock worth $253,000 after buying an additional 182 shares during the period. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Henry Schein Trading Up 0.3%

Shares of HSIC opened at $73.22 on Wednesday. The firm has a market cap of $8.62 billion, a P/E ratio of 23.62, a price-to-earnings-growth ratio of 2.06 and a beta of 0.84. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.41 and a quick ratio of 0.78. Henry Schein, Inc. has a 1 year low of $60.56 and a 1 year high of $82.49. The company has a 50 day simple moving average of $66.46 and a two-hundred day simple moving average of $68.86.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, November 4th. The company reported $1.38 earnings per share for the quarter, topping analysts’ consensus estimates of $1.27 by $0.11. The firm had revenue of $3.34 billion during the quarter, compared to analyst estimates of $3.28 billion. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. Henry Schein has set its FY 2025 guidance at 4.880-4.960 EPS. On average, equities analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on HSIC shares. Wells Fargo & Company boosted their price objective on Henry Schein from $70.00 to $76.00 and gave the company an “equal weight” rating in a research note on Wednesday, November 5th. Evercore ISI upped their price target on shares of Henry Schein from $83.00 to $90.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 5th. Stifel Nicolaus reissued a “hold” rating and issued a $75.00 price objective (down from $80.00) on shares of Henry Schein in a research note on Friday, July 25th. JPMorgan Chase & Co. raised their price objective on shares of Henry Schein from $76.00 to $78.00 and gave the company an “overweight” rating in a research report on Wednesday, November 5th. Finally, Barrington Research set a $79.00 target price on shares of Henry Schein and gave the stock an “outperform” rating in a report on Wednesday, November 5th. Five research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $76.08.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.